Anal Cancer Therapeutics Market Analysis Devices, By Top Key Players, Global Industry Size 2025

Leading Market Manufacturers

Amgen Inc. (US), Bristol-Myers Squibb Company (US), Celgene Corporation (US), Eli Lilly and Company (US), F. Hoffmann-La Roche Ltd (Switzerland), Merck & Co., Inc. (US ), Novartis AG (Switzerland), Pfizer Inc. (US), GlaxoSmithKline plc (UK), Sanofi (France), Johnson & Johnson Services, Inc. (US) and Hospira, Inc. (US)

Global Anal Cancer Market share Research Report: Information by Cancer Type (Carcinoma in Situ, Squamous Cell Carcinoma, Adenocarcinoma, Basal Cell Carcinoma, Melanoma and others), Treatment Type (Chemotherapy, Surgery, Radiation Therapy and Immunotherapy), End User (Hospitals & Clinics, Research & Academic Institutes and others) and Region (the Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2025, Confirms MRFR

Anal Cancer Market Overview

Anal cancer is cancer of the anus or the surrounding area. Anal cancer can be caused by all of the regular causes of cancer, ie smoking, chewing tobacco, radiation poisoning, etc., but can also be caused by the HPV virus. In fact, HPV accounts for more than 90% of all anal cancers, making it a closely associated pathogen. Anal cancer is rarely found in younger demographics, with people above 60 being the prime candidate for the disease. It is estimated to cause more than 8,000 new cases in the US in 2019, accompanied by more than a thousand deaths. The five-year survival rate for anal cancer is 66%, a considerable improvement upon some other types of cancer but worrying nevertheless.

Segmentation:

Global anal cancer market has been segmented on the basis of type into squamous cell carcinoma, adenocarcinoma, perianal skin cancer, melanoma, and others.

On the basis of treatment, the global anal cancer market is segmented into chemotherapy, radio therapy, surgery, and others.

On the basis of end user, the global anal cancer market is segmented into hospitals, clinics, research institutes, and others.

Key Questions Answered in This Report:

  • What will the market size and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

 

Access the complete report @ https://www.marketresearchfuture.com/reports/anal-cancer-market-1530

Industry / Innovation / Related News:

November 30, 2018 - A research group at the University of Alabama (US), published their findings of the study they carried out for the treatments and vaccinations that can be repurposed for HPVs. Preclinical experiments indicated towards the cancer drugs vorinostat, belinostat and panobinostat that can be repurposed to treat infections caused by human papillomaviruses, or HPV.

Related News

Global Rheumatoid arthritis Market Research Report- Forecast To 2022

 

Global Perfusion Imaging Market Research Report Forecast To 2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR ), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact

https://www.marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Root Canal Market share Valuation, Trends and Forecast to 2027

  The Global Root Canal Market could touch the valuation of USD 21.0 billion by 2023, asserts Market Research Future (MRFR). It is expected to achieve a CAGR of 8.0 % during the forecast period (2017-2023). Growth Drivers and Key Barriers The global root canal market benefits from the rising demand for the treatment owing to the expanding population and the subsequent surge in the number of procedures performed. The boost in number of screenings, greater stress on restorative dental procedures, greater consumption of starch-rich diets and fast foods and rising efficacy, efficiency and success rate of root canal treatment has taken the market to greater heights.  Having said that, the high cost of root canal treatment could act as a barrier for the market in the near future. However, as product development is one of the best strategies for market growth, the market could observe exponential growth in the coming years. This factor stands true on the back of technological advancements
Read more

Hiv diagnosis treatment market size, Overview By , Share, Trends 2027

  Study objectives of Middle East and Africa HIV Diagnosis & Treatment Market: To provide detailed analysis of the market structure along with forecast for the next 6 years of the various segments and sub-segments of the  Middle East and Africa HIV Diagnosis & Treatment Market To provide insights about factors affecting the market growth in this region To analyze the Middle East and Africa HIV Diagnosis & Treatment Market based on various factors - price analysis, supply chain analysis, Porters Five Forces analysis etc. To provide historical and forecast revenue of the market segments and sub-segments with respect to two main geographies and their countries To provide detailed analysis of the market with respect to the current market size and future prospective To provide detailed analysis of the market for segments by diagnosis, by treatment, and its sub-segments. To provide overview of key players and their strategic profiling in the market, comprehensively analyzi
Read more